Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.India rejects patent application for Abbott’s HIV drug combination
The rejection of this patent application by The Indian Patent Office was for a combination of existing drugs and techniques. Following this decision, India can now supply this
The rejection of this patent application by The Indian Patent Office was for a combination of existing drugs and techniques. Following this decision, India can now supply this
VX15/2503 is a humanized antibody that blocks the activity of semaphorin 4D (SEMA4D). Vaccinex plans to initiate a second trial of VX15/2503 for MS later this year. Vaccinex
The new patent entitled, ‘Inhibitors of Serine Protease Activity and Their Use in Methods and Compositions for Treatment of Bacterial Infections,’ covers inhibition of all forms of Bacillus
ISIS-EIF4ERx targets the gene that is responsible for the production of a protein, eIF-4E, which is over-expressed in a variety of cancers, including prostate, lung, ovarian, liver, breast,
The recommended oral dose of Intelence tablets is 200 mg (one 200mg tablet or two 100mg tablets) taken twice daily after a meal. This new 200mg product formulation
Fusilev, a novel folate analog, is available in vials as freeze-dried powder. Fusilev is also indicated to diminish the toxicity and counteract the effects of impaired methotrexate elimination
Kiadis Pharma claims that ATIR will enable a mismatched family member to act as donor and is being developed to reduce transplant related mortality caused by infections and
In his new role, Baly will be responsible for cross-divisional management of marketing, sales and service for the Sartorius laboratory business. Most recently, Baly worked with Millipore Corporation
Androxal is an orally active small molecule under development that restores normal pituitary response in men resulting in normalization of testosterone and luteinizing hormone (LH) levels. Repros expects
Earlier in 14 December 2010, Meda took over three OTC consumer products from GSK. Meda is an international specialty pharma company engaged in marketing and product development in